Tweetovi
- Tweetovi, trenutna stranica.
- Tweetovi i odgovori
- Medijski sadržaj
Blokirali ste korisnika/cu @EMJHematology
Jeste li sigurni da želite vidjeti te tweetove? Time nećete deblokirati korisnika/cu @EMJHematology
-
This article introduces a rare case of a sickle cell disease patient who as a result of acute intrahepatic cholestasis experienced severe complications. To learn more, visit: https://bit.ly/3aYteca
#SickleCell#IntrahepaticCholestasisHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Therapeutic Options in Myelodysplastic Syndromes Following Hypomethylating Agent Failure. The table shows an International Prognostic Scoring System (IPSS). To learn more, visit: https://bit.ly/2UdQyg5 pic.twitter.com/lQm6CaTZ5S
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
EMJ Hematology US Edition is the newest addition to our
#haematology collection, and contains a review of the 61st American Society of#Hematology (ASH) Annual Meeting and Exposition. Be sure to read it today: https://bit.ly/37LCT3N#ASH2019pic.twitter.com/zqoqUrGRgZ
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Have a read of EMJ and find our
#Hematology abstracts just here!http://ow.ly/9VxJ30qd0UPHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Tagraxofusp is a Novel Targeted Therapy Directed to CD123http://ow.ly/hBtD30qd0UO
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Explore all EMJ
#Hematology content of articles, abstract and interviews here!http://ow.ly/KoK030qd0UNHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Autologous Dendritic Cell Vaccination to Prevent Progression and Relapse in Multiple Myelomahttp://ow.ly/EvnA30qd0UM
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
With over 30,000 delegates in attendance, this bustling congress was packed full of ground-breaking research and discussion of the most pressing topics in
#haematology. Be sure to check out the full congress review here: https://bit.ly/2O2Pms4#ASH2019#ASHCongresspic.twitter.com/vIxJJtGDtbHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
This case report by Ammouri et al. presents an astute view of the complexity and various presentations of pernicious
#anaemia and novel approaches regarding its diagnosis, pathogenesis, and clinical presentation. https://bit.ly/2RSs7SG#HematologyHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Brand new articles, abstract summaries and captivating interviews from the field of
#Hematology. Explore our hematology collection today: https://bit.ly/2RLA3VS pic.twitter.com/PIgSuaohmq
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
EMJ Hematology US Edition 1.1 presents the latest coverage from the 2019 American Society of
#Hematology (ASH) meeting in#Orlando. Our first US-affiliated journal includes committee member interviews, abstract reviews and much more. Read it here: https://bit.ly/38tlKvU#ASH2019pic.twitter.com/tx14XGRKA7
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
@EMJHematology will soon be publishing its first US Edition Journal providing a wide-ranging review of the 61st American Society of#Hematology (ASH). Subscribe here to be notified on publication day: https://bit.ly/2sRDmCz pic.twitter.com/rBEJ4APuoN
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Throw it all the way back to EMJ
#Hematology 7.1.#TBThttp://ow.ly/LKt230pTsRmHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Gilteritinib Plus Azacitidine in Newly Diagnosed FLT3 Mutated (FLT3mut+) Acute Myeloid
#Leukaemia Patients Ineligible for Intensive Induction#Chemotherapy: Preliminary Findings from the Safety Cohort: https://bit.ly/2pGfhgh pic.twitter.com/sAz6qDMR9O
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
For the latest developments in
#Hematology, subscribe to EMJ http://ow.ly/Dt6l30pVtH1 pic.twitter.com/R8ROUg26Lt
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
xamples of Epstein–Barr virus-positive diffuse large B cell
#lymphoma (A, B, C) and Epstein–Barr virus mucocutaneous#ulcer (D, E, F). https://bit.ly/2stwj2z#Hematologypic.twitter.com/yrb8Wdcd7V
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Therapeutic Options in Myelodysplastic Syndromes: Established and Emerging Therapies. The table shows an international prognostic scoring system for the stratification of myelodysplastic syndromes. https://bit.ly/2Nz87Dq
#Hematologypic.twitter.com/sUvZ0dy01s
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Take a moment to enjoy some EMJ
#Hematology video content, just follow this link: http://ow.ly/kPJH30pXC2Q pic.twitter.com/k4VwXNoBNI
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi
-
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi
Čini se da učitavanje traje već neko vrijeme.
Twitter je možda preopterećen ili ima kratkotrajnih poteškoća u radu. Pokušajte ponovno ili potražite dodatne informacije u odjeljku Status Twittera.